US Stock MarketDetailed Quotes

IDXX IDEXX Laboratories Inc

Watchlist
  • 458.050
  • +0.240+0.05%
Trading Feb 27 10:10 ET
37.25BMarket Cap42.93P/E (TTM)

IDEXX Laboratories Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IDEXX Laboratories Inc Q4 2024 Earnings Date

Currency：USDFeb 3, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
936.68M
954.29M
+17.61M
Beat Est.
+3.89%
+5.84%
+1.88%
EPS
2.40
2.62
+0.22
Beat Est.
+3.63%
+12.93%
+8.98%
Analyst Rating
Buy

Feb 10, 2025

IDEXX Laboratories Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.056B--
--2025/Q1-- / 998.246M--
Feb 3, 20252024/Q4954.288M / 936.676M--
Oct 31, 20242024/Q3975.543M / 980.961M--
Aug 6, 20242024/Q21.004B / 1.004B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.056B--
--2025/Q1-- / 998.246M--
Feb 3, 20252024/Q4954.288M / 936.676M--
Oct 31, 20242024/Q3975.543M / 980.961M--
Aug 6, 20242024/Q21.004B / 1.004B--

Unlock Free Earnings Estimates

IDEXX Laboratories Inc Earnings Reports

  • IDEXX Laboratories Inc | 10-K: FY2024 Annual Report

    Feb 21 08:31 ET

  • IDEXX Laboratories Inc | 8-K: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

    Feb 3 10:21 ET

  • IDEXX Laboratories Inc | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 16:23 ET

  • IDEXX Laboratories Inc | 8-K/A: IDEXX Laboratories Announces Third Quarter Results

    Oct 31, 2024 13:25 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.78%
    Halozyme Therapeutics
    HALO
    +1.07%
    Hutchmed (China)
    HCM
    +0.66%
    Collegium Pharmaceutical
    COLL
    +0.69%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 10, 2025

    Buy

    • Buy

      62.50%

    • Hold

      37.50%

    • Sell

      0.00%

    Price Target

    No Data